PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.76%
Revenue growth under 50% of SEDG's 9.65%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-2.26%
Negative gross profit growth while SEDG is at 10.48%. Joel Greenblatt would examine cost competitiveness or demand decline.
-171.19%
Negative EBIT growth while SEDG is at 21.41%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
27.21%
Operating income growth 1.25-1.5x SEDG's 19.54%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
-212.19%
Negative net income growth while SEDG stands at 17.64%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-213.95%
Negative EPS growth while SEDG is at 16.09%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-225.64%
Negative diluted EPS growth while SEDG is at 17.07%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.14%
Share reduction more than 1.5x SEDG's 0.54%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-11.05%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-207.64%
Negative OCF growth while SEDG is at 59.71%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-221.36%
Negative FCF growth while SEDG is at 1715.91%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-73.93%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-64.53%
Negative 5Y CAGR while SEDG stands at 221.58%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-38.36%
Negative 3Y CAGR while SEDG stands at 93.80%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-162.53%
Negative 10Y OCF/share CAGR while SEDG stands at 187.01%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
85.23%
5Y OCF/share CAGR at 75-90% of SEDG's 99.00%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
88.04%
3Y OCF/share CAGR above 1.5x SEDG's 56.73%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
87.07%
Net income/share CAGR at 50-75% of SEDG's 153.12%. Martin Whitman might question if the firm’s product or cost base lags behind.
-66.36%
Negative 5Y net income/share CAGR while SEDG is 166.64%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
23.38%
3Y net income/share CAGR above 1.5x SEDG's 1.23%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-82.27%
Negative equity/share CAGR over 10 years while SEDG stands at 863.35%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-77.05%
Negative 5Y equity/share growth while SEDG is at 254.59%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
633.78%
3Y equity/share CAGR above 1.5x SEDG's 100.73%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.90%
AR growth is negative/stable vs. SEDG's 21.12%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
2.37%
We show growth while SEDG is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-7.62%
Negative asset growth while SEDG invests at 3.61%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-17.46%
We have a declining book value while SEDG shows 4.90%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-3.83%
We’re deleveraging while SEDG stands at 0.14%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-36.77%
Our R&D shrinks while SEDG invests at 5.70%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-9.80%
We cut SG&A while SEDG invests at 3.39%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.